Next Quarterly Earnings
Tuesday, August 4, 2026
CW 32
After-Hours
In 30 days
MiMedx Group
MiMedx Group is a leading US-based regenerative medicine company. It develops and distributes innovative biopharmaceutical products derived from human amniotic tissue. The company focuses on solutions for wound healing, orthopedic surgery, and musculoskeletal conditions.
All Dates
Earnings history data not available
Company Information
Name
MiMedx Group
Country
đșđž
More Financial Information